International Journal of Cancer Management

Published by: Kowsar

ALK Positive Anaplastic Large Cell Lymphoma of Oral Cavity: A Case Report

Fatemeh Nili 1 , Vahid Soleimani 1 , Niusha Nobari 1 , Hana Saffar 1 and Arghavan Etebarian 2 , *
Authors Information
1 Pathology Department, Cancer Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
2 Department of Oral and Maxillofacial Pathology, School of Dentistry, Alborz University of Medical Sciences, Karaj, Iran
Article information
  • International Journal of Cancer Management: 12 (1); e85749
  • Published Online: January 27, 2019
  • Article Type: Case Report
  • Received: October 25, 2018
  • Revised: January 14, 2019
  • Accepted: January 15, 2019
  • DOI: 10.5812/ijcm.85749

To Cite: Nili F, Soleimani V, Nobari N, Saffar H, Etebarian A. ALK Positive Anaplastic Large Cell Lymphoma of Oral Cavity: A Case Report, Int J Cancer Manag. Online ahead of Print ; 12(1):e85749. doi: 10.5812/ijcm.85749.

Abstract
Copyright © 2019, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Case Presentation
3. Discussion
Acknowledgements
Footnotes
References
  • 1. Falini B, Pileri S, Zinzani PL, Carbone A, Zagonel V, Wolf-Peeters C, et al. ALK+ lymphoma: Clinico-pathological findings and outcome. Blood. 1999;93(8):2697-706. [PubMed: 10194450].
  • 2. Ferreri AJ, Govi S, Pileri SA, Savage KJ. Anaplastic large cell lymphoma, ALK-positive. Crit Rev Oncol Hematol. 2012;83(2):293-302. doi: 10.1016/j.critrevonc.2012.02.005. [PubMed: 22440390].
  • 3. Stein H, Foss HD, Durkop H, Marafioti T, Delsol G, Pulford K, et al. CD30(+) anaplastic large cell lymphoma: A review of its histopathologic, genetic, and clinical features. Blood. 2000;96(12):3681-95. [PubMed: 11090048].
  • 4. ten Berge RL, Oudejans JJ, Ossenkoppele GJ, Meijer CJ. ALK-negative systemic anaplastic large cell lymphoma: Differential diagnostic and prognostic aspects--a review. J Pathol. 2003;200(1):4-15. doi: 10.1002/path.1331. [PubMed: 12692835].
  • 5. Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DN, Saltman DL, et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science. 1994;263(5151):1281-4. doi: 10.1126/science.8122112. [PubMed: 8122112].
  • 6. Holla VR, Elamin YY, Bailey AM, Johnson AM, Litzenburger BC, Khotskaya YB, et al. ALK: A tyrosine kinase target for cancer therapy. Cold Spring Harb Mol Case Stud. 2017;3(1). a001115. doi: 10.1101/mcs.a001115. [PubMed: 28050598]. [PubMed Central: PMC5171696].
  • 7. Mologni L. Current and future treatment of anaplastic lymphoma kinase-rearranged cancer. World J Clin Oncol. 2015;6(5):104-8. doi: 10.5306/wjco.v6.i5.104. [PubMed: 26468446]. [PubMed Central: PMC4600184].
  • 8. Amin HM, Lai R. Pathobiology of ALK+ anaplastic large-cell lymphoma. Blood. 2007;110(7):2259-67. doi: 10.1182/blood-2007-04-060715. [PubMed: 17519389]. [PubMed Central: PMC1988960].
  • 9. George SK, Vishwamitra D, Manshouri R, Shi P, Amin HM. The ALK inhibitor ASP3026 eradicates NPM-ALK(+) T-cell anaplastic large-cell lymphoma in vitro and in a systemic xenograft lymphoma model. Oncotarget. 2014;5(14):5750-63. doi: 10.18632/oncotarget.2170. [PubMed: 25026277]. [PubMed Central: PMC4170597].
  • 10. Kadin ME, Morris SW. The t(2;5) in human lymphomas. Leuk Lymphoma. 1998;29(3-4):249-56. doi: 10.3109/10428199809068562. [PubMed: 9684923].
  • 11. Burkhardt B, Zimmermann M, Oschlies I, Niggli F, Mann G, Parwaresch R, et al. The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence. Br J Haematol. 2005;131(1):39-49. doi: 10.1111/j.1365-2141.2005.05735.x. [PubMed: 16173961].
  • 12. Narwal A, Yadav AB, Prakash S, Gupta S. Anaplastic lymphoma kinase negative anaplastic large cell lymphoma of hard palate as first clinical manifestation of acquired immune deficiency syndrome. Contemp Clin Dent. 2016;7(1):114-7. doi: 10.4103/0976-237X.177115. [PubMed: 27041916]. [PubMed Central: PMC4792042].
  • 13. Matsumoto N, Ohki H, Mukae S, Amano Y, Harada D, Nishimura S, et al. Anaplastic large cell lymphoma in gingiva: Case report and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;106(4):e29-34. doi: 10.1016/j.tripleo.2008.05.037. [PubMed: 18656392].
  • 14. Savarrio L, Gibson J, Dunlop DJ, O'Rourke N, Fitzsimons EJ. Spontaneous regression of an anaplastic large cell lymphoma in the oral cavity: First reported case and review of the literature. Oral Oncol. 1999;35(6):609-13. doi: 10.1016/S1368-8375(99)00034-2. [PubMed: 10705098].
  • 15. Kemp S, Gallagher G, Kabani S, Noonan V, O'Hara C. Oral non-Hodgkin's lymphoma: Review of the literature and World Health Organization classification with reference to 40 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105(2):194-201. doi: 10.1016/j.tripleo.2007.02.019. [PubMed: 17604660].
  • 16. Notani KI, Shindoh M, Takami T, Yamazaki Y, Kohgo T, Fukuda H. Anaplastic large cell lymphoma (ALCL) in the oral mucosa with repeating recurrence and spontaneous regression of ulceration: report of a case. Oral Med Pathol. 2002;7(2):79-82. doi: 10.3353/omp.7.79.
  • 17. Epstein JB, Epstein JD, Le ND, Gorsky M. Characteristics of oral and paraoral malignant lymphoma: A population-based review of 361 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;92(5):519-25. doi: 10.1067/moe.2001.116062. [PubMed: 11709688].
  • 18. Stein H, Mason DY, Gerdes J, O'Connor N, Wainscoat J, Pallesen G, et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood. 1985;66(4):848-58. [PubMed: 3876124].
  • 19. Andreesen R, Brugger W, Lohr GW, Bross KJ. Human macrophages can express the Hodgkin's cell-associated antigen Ki-1 (CD30). Am J Pathol. 1989;134(1):187-92. [PubMed: 2536522]. [PubMed Central: PMC1879544].
  • 20. Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375-90. doi: 10.1182/blood-2016-01-643569. [PubMed: 26980727]. [PubMed Central: PMC4874220].
  • 21. Rodriguez J, Gutierrez A, Martinez-Delgado B, Perez-Manga G. Current and future aggressive peripheral T-cell lymphoma treatment paradigms, biological features and therapeutic molecular targets. Crit Rev Oncol Hematol. 2009;71(3):181-98. doi: 10.1016/j.critrevonc.2008.10.011. [PubMed: 19056295].
  • 22. Gambacorti Passerini C, Farina F, Stasia A, Redaelli S, Ceccon M, Mologni L, et al. Crizotinib in advanced, chemoresistant anaplastic lymphoma kinase-positive lymphoma patients. J Natl Cancer Inst. 2014;106(2):djt378. doi: 10.1093/jnci/djt378. [PubMed: 24491302].
  • 23. Savage KJ, Harris NL, Vose JM, Ullrich F, Jaffe ES, Connors JM, et al. ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: Report from the International Peripheral T-Cell Lymphoma Project. Blood. 2008;111(12):5496-504. doi: 10.1182/blood-2008-01-134270. [PubMed: 18385450].
  • 24. Piva R, Agnelli L, Pellegrino E, Todoerti K, Grosso V, Tamagno I, et al. Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms. J Clin Oncol. 2010;28(9):1583-90. doi: 10.1200/JCO.2008.20.9759. [PubMed: 20159827].
  • 25. Tilly H, Gaulard P, Lepage E, Dumontet C, Diebold J, Plantier I, et al. Primary anaplastic large-cell lymphoma in adults: Clinical presentation, immunophenotype, and outcome. Blood. 1997;90(9):3727-34. [PubMed: 9345059].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments